Breast Cancer News and Research

Latest Breast Cancer News and Research

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

New treatment significantly improves long-term outlook for breast cancer survivors

An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.

11 Jun 2004

Blood test that can detect amplification of a certain gene found in cells associated with breast cancer

Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.

10 Jun 2004

Magnetic resonance imaging better than traditional mammography for detecting the presence of breast cancer

Researchers from the Abramson Cancer Center of the University of Pennsylvania today presented the first comprehensive study results which show that magnetic resonance imaging (MRI) is significantly better than traditional mammography for detecting the presence and extent of disease in patients with a diagnosis of breast cancer.

10 Jun 2004

Improving access to mammographies offers greatest potential for reducing lives lost to breast cancer

While new technologies hold promise for increasing the accuracy of breast cancer detection, improving access to mammography and broadening the pool of medical personnel who can interpret mammograms offer the greatest potential for immediately reducing the number of lives lost to breast cancer in the United States

10 Jun 2004

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Breast cancer patients with advanced disease live longer when treated with a new drug, gemcitabine, in combination with paclitaxel, a traditional drug, according to results of a landmark global phase III study

9 Jun 2004

New blood test may help detect breast cancer

Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.

9 Jun 2004

Changing practices may raise African American women's breast cancer risk

A new study finds African American women derive similar breast cancer risk reductions associated with multiple births and breastfeeding as white women, but that recent trends may lead to a rising risk.

7 Jun 2004

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.

7 Jun 2004

Herceptin shows real promise in treatment of HER-2 positive breast disease

According to a study conducted at The University of Texas M. D. Anderson Cancer Center, more than twice as many women with early stage, HER-2 positive breast disease who received Herceptin as part of their pre-surgery chemotherapy had their tumors completely disappear compared to like patients who received only chemotherapy.

7 Jun 2004

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

Newest research findings were presented on the possible benefits they may provide for postmenopausal breast cancer risk reduction. SERMs are a class of drugs that can block the cell's ability to use estrogen to stimulate the development of breast cancer.

7 Jun 2004

Gemcitabine may help breast cancer patients with advanced disease live longer

6 Jun 2004

High school student makes significant contribution to breast cancer research

A high school student from Albany, New York, has made a significant contribution toward understanding how mutations to a gene called BRCA-1 contributes to hereditary breast cancer.

5 Jun 2004

60,000 set to run in race for the cure

Participants at the Susan G. Komen Breast Cancer Foundation National Race for the Cure® were among the first to view a new breast cancer ribbon today as they descended on the National Mall.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004